使用MD和AIDD方法探索同源蛋白BD1/BD2的选择性潜在抑制剂
Mengxia Zhao1, Junfeng Wan1, Yiru Wang1
1College of Mathematics and Physics, Shanghai University of Electric Power, Shanghai, 201306, China.
Current computer-aided drug design
|October 2, 2025
概括
研究人员确定了含有原体蛋白4 (BRD4) 域BD1/BD2的选择性抑制剂,这对于三阴性乳腺癌 (TNBC) 治疗至关重要. 分子动力学模拟揭示了特定的结合机制,有助于未来的药物设计.
科学领域:
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
- 计算化学计算化学
背景情况:
- 含基因的蛋白4 (BRD4) 是一种表观遗传调节剂,与三阴性乳腺癌 (TNBC) 有关.
- 由于它们的结构相似性,选择性抑制BRD4同源BD1/BD2域具有挑战性.
- 向BRD4为TNBC提供了治疗潜力.
研究的目的:
- 确定针对BRD4.4的BD1和BD2域的选择性抑制剂.
- 阐明这些抑制剂与BRD4 BD1/BD2.2.的结合机制.
- 克服在实现BRD4.4域特异性抑制方面的挑战.
主要方法:
- 使用AutoDock vina. 选传统中国草药 (TCM) 的潜在抑制剂.
- 分子动力学 (MD) 模拟用于研究抑制剂-蛋白相互作用.
- 使用FL-411作为参考抑制剂进行实验比较.
主要成果:
- 发现抑制剂可以稳定BRD4 BD1/BD2形状.
- 与抑制剂一起观察到增强的疏水和盐桥相互作用.
- 确定了特定的原子相互作用:FL-411与BD1的E85,米尔蒂龙与BD2的H437,证明了选择性.
结论:
- 确定了BRD4 BD1/BD2选择性的关键结构决定因素.
- MD模拟验证了查方法,并证实了实验结果.
- 人工智能药物发现 (AIDD) 产生了具有改善结合亲和力的新兴抑制剂.
更多相关视频
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
2.5K
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
949
相关概念视频
Ligand Binding Sites
11.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
